Home /LOBBYING OF HEALTH ORGANIZATIONS IN THE U.S.
LOBBYING OF HEALTH ORGANIZATIONS IN THE U.S.
Submitted by christian on Tue, 04/20/2021 - 15:38
COVID 19 has led to a significant surge in health sector lobbying activity, especially within the pharmaceutical industry. Four segments—pharmaceutical , hospital , health insurance , and professional services accounted for 70.7% of the lobbying expenditures in the health sector. For COVID-19 lobbying, these segments accounted for 64.2% (26.4% for pharmaceutical, 13.4% for hospitals, 12.0% for health insurance and 12.4% for professional services. Across all segments of health sector lobbying, the biggest lobbying increases came from the pharmaceutical industry.
